Former Damon Runyon Scholar Peter S. Nelson, MD, and colleagues at the Fred Hutchinson Cancer Research Center have completed the first comprehensive analysis of the advanced prostate cancer genome, identifying key genetic mutations that drive the disease and cause resistance to treatment.

While progress against prostate cancer has been significant, several forms of the disease remain highly lethal and stubbornly resistant to standard treatments.  The results reported by Peter mark the first time scientists have been able to identify the unique genetic mutations that distinguish advanced prostate tumors from each other and their less-lethal cousins.

> Read the whole post: “Advanced Prostate Cancer Genome Mapped”